Company / Operating Margin
Traws Pharma, Inc. Operating Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-62997.3%
FY2024
5-year range
-62997.3% / -994.0%
FY2020-FY2024
Trend
-625.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -625% YoY in FY2024, a notable deviation from the 9-year average annual change of -243%.
Based on SEC 10-K filings.
-62997.3% in FY2024 with a 5-year CAGR of -61101.4%.
Declined from -7299.1% to -62997.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -52177.9pp
- 5-Year Change
- -61101.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 625.4% year-over-year.
- Peak operating margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -62997.3% | -625.4% |
| FY2023 | -8684.5% | -19.0% |
| FY2022 | -7299.1% | +32.5% |
| FY2021 | -10819.5% | -988.5% |
| FY2020 | -994.0% | +47.6% |
| FY2019 | -1895.9% | +42.0% |
| FY2018 | -3270.3% | -665.2% |
| FY2017 | -427.4% | -104.2% |
| FY2016 | -209.2% | +97.4% |
| FY2015 | -7968.0% | -16420.8% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026